The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD

NCT07289750 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

T2DM
MAFLD

Interventions

DRUG: alogliptin and actoplus met
DRUG: actoplus met

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine